{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:03:29Z","timestamp":1790175809217,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1097\/jcp.013e3180dcc304d","type":"journal-article","created":{"date-parts":[[2007,7,9]],"date-time":"2007-07-09T08:05:22Z","timestamp":1183968322000},"page":"357-364","source":"Crossref","is-referenced-by-count":77,"title":["Outcome of Pharmacological Treatments of Pathological Gambling"],"prefix":"10.1097","volume":"27","author":[{"given":"St\u00e5le","family":"Pallesen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Molde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga Myrseth","family":"Arnestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Christian","family":"Laberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvid","family":"Skutle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge Jarl","family":"St\u00f8ylen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Kvale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Holsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.1968.01740050105018","article-title":"Gambling and the gambler. A review and preliminary findings.","volume":"18","author":"Bolen","year":"1968","journal-title":"Arch of Gen Psychiatry"},{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.2105\/AJPH.89.9.1369","article-title":"Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis.","volume":"89","author":"Shaffer","year":"1999","journal-title":"Am J Public Health"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1360-0443.2005.01204.x","article-title":"Outcome of psychological treatments of pathological gambling: a review and meta-analysis.","volume":"100","author":"Pallesen","year":"2005","journal-title":"Addiction"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00023210-200013060-00002","article-title":"Epidemiology, pathophysiology and treatment of pathological gambling.","volume":"13","author":"Blanco","year":"2000","journal-title":"CNS Drugs"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"559","DOI":"10.4088\/JCP.v63n0704","article-title":"Lithium and valproate treatment of pathological gambling: a randomized single-blind study.","volume":"63","author":"Pallanti","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.yic.0000073881.93678.21","article-title":"Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial.","volume":"18","author":"Grant","year":"2003","journal-title":"Int Clin Psychopharmacol"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/10401230209147393","article-title":"A pilot placebo-controlled study of fluvoxamine for pathological gambling.","volume":"14","author":"Blanco","year":"2002","journal-title":"Ann Clin Psychiatry"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/B:JOGS.0000040280.64348.d1","article-title":"Not the same: a comparison of female and male clients seeking treatment from problem gambling counselling services.","volume":"20","author":"Crisp","year":"2004","journal-title":"J Gambl Stud"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00008571-199710000-00001","article-title":"Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene.","volume":"7","author":"de Castro","year":"1997","journal-title":"Pharmacogenetics"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/appi.ajp.162.1.137","article-title":"Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?","volume":"162","author":"Hollander","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R12-6-20210128","first-page":"86","article-title":"Naltrexone in the treatment of pathological gambling and alcohol dependence.","volume":"43","author":"Crockford","year":"1998","journal-title":"Can J Psychiatry"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0005-7967(02)00036-0","article-title":"Group therapy for pathological gamblers: a cognitive approach.","volume":"41","author":"Ladouceur","year":"2003","journal-title":"Behav Res Ther"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/10401230209147452","article-title":"Effectiveness of pharmacotherapy for pathological gambling: a chart review.","volume":"14","author":"Grant","year":"2002","journal-title":"Ann Clin Psychiatry"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/01.jcp.0000114844.58996.4a","article-title":"An open-label trial of bupropion in the treatment of pathological gambling.","volume":"24","author":"Black","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/01.wnf.0000152623.46474.07","article-title":"Topirmate versus fluvoxamine in the treatment of pathological gambling.","volume":"28","author":"Dannon","year":"2005","journal-title":"Clin Neuropharmacol"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.jcp.0000186867.90289.ed","article-title":"Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study.","volume":"26","author":"Dannon","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1176\/appi.ajp.163.2.303","article-title":"Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.","volume":"163","author":"Grant","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00004850-200607000-00002","article-title":"Escitalopram treatment of pathological gambling with co-occuring anxiety: an open-label pilot study with double-blind discontinuation.","volume":"21","author":"Grant","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0006-3223(00)00241-9","article-title":"A randomized double-blind fluvoxamine\/placebo crossover trial in pathologic gambling.","volume":"47","author":"Hollander","year":"2000","journal-title":"Biol Psychiarty"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00004850-200109000-00006","article-title":"An open naltrexone treatment study in pathological gambling disorder.","volume":"16","author":"Kim","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0006-3223(01)01079-4","article-title":"Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling.","volume":"49","author":"Kim","year":"2001","journal-title":"Biol Psychiatry"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4088\/JCP.v63n0606","article-title":"A double-blind placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling.","volume":"63","author":"Kim","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.4088\/JCP.v63n1114","article-title":"Nefazodone treatment of pathological gambling: a prospective open-label controlled trial.","volume":"63","author":"Pallanti","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4088\/JCP.v66n0104","article-title":"Sertraline treatment of pathological gambling: a pilot study.","volume":"66","author":"Saiz-Ruiz","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4088\/JCP.v63n0109","article-title":"An open-label study of citalopram in the treatment of pathological gambling.","volume":"63","author":"Zimmerman","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"R30-6-20210128","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/jama.282.11.1054","article-title":"The hazards of scoring the quality of clinical trials for meta-analysis.","volume":"282","author":"Juni","year":"1999","journal-title":"J Am Med Dir Assoc"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1037\/0033-2909.108.1.30","article-title":"Psychotherapy for the treatment of depression: a comprehensive review of controlled outcome research.","volume":"108","author":"Robinson","year":"1990","journal-title":"Psychol Bull"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00938026","article-title":"A practitioner's guide to meta-analysis.","volume":"19","author":"Durlak","year":"1991","journal-title":"Am J Community Psychol"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1037\/0033-2909.86.3.638","article-title":"The file drawer problem and tolerance for null results.","volume":"86","author":"Rosenthal","year":"1979","journal-title":"Psychol Bull"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1037\/0022-006X.71.4.643","article-title":"Psychological treatment of late-life anxiety: an empirical review.","volume":"71","author":"Norhus","year":"2003","journal-title":"J Consult Clin Psychol"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1360-0443.2005.01341.x","article-title":"A framework for reporting outcomes in problem gambling treatment research: The Banff, Alberta Consensus.","volume":"101","author":"Walker","year":"2006","journal-title":"Addiction"},{"key":"R39-6-20210128","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1037\/0003-066X.47.9.1102","article-title":"In search of how people change-applications to addictive behaviors.","volume":"47","author":"Prochaska","year":"1992","journal-title":"Am Psychol"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/10401230500295636","article-title":"Gender differences in adolescent gambling.","volume":"17","author":"Desai","year":"2005","journal-title":"Ann Clin Psychiatry"},{"key":"R41-6-20210128","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4088\/JCP.v64n0413","article-title":"Factors at play in faster progression for female pathological gamblers: an explanatory analysis.","volume":"64","author":"Tavares","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R42-6-20210128","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1037\/0893-164X.19.2.226","article-title":"Childhood maltreatment in male and female treatment-seeking pathological gamblers.","volume":"19","author":"Petry","year":"2005","journal-title":"Psychol Addict Behav"},{"key":"R43-6-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.mp.4000654","article-title":"Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes.","volume":"5","author":"Ibanez","year":"2002","journal-title":"Mol Psychiatry"},{"key":"R44-6-20210128","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/da.10134","article-title":"Does elimination of placebo responders in a placebo run increase the treatment effect in randomized clinical trials? A meta-analytic evaluation.","volume":"19","author":"Lee","year":"2004","journal-title":"Depress Anxiety"},{"key":"R45-6-20210128","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/scnp.2001.22924","article-title":"The psychopharmacology of pathological gambling.","volume":"6","author":"Kim","year":"2001","journal-title":"Semin Clin Neuropsychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-200708000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T13:43:24Z","timestamp":1708091004000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200708000-00006"}},"subtitle":["A Review and Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.013e3180dcc304d","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}